Piramal Pharma to sell its decommissioned Thane unit to Global Pharma for ₹8.5 crore; deal expected in 90 days.

• A sale involves an unused unit contributing nothing to turnover or net worth in the last financial year.
• Transaction structured via sale deed and definitive agreements; no operational impact expected post-sale.
• Sale is part of routine asset optimization as the company focuses on core operations and efficiency improvements.